Next issueIssue 23 · Tue 17 Nov 

Trials

NCT07219953

Trial ID
T-ctgov-NCT07219953
Registry
ClinicalTrials.gov
NCT number
NCT07219953
CTIS number
2025-522312-16-00
Sponsor, as registered
Eli Lilly and Company
Phase
PHASE3
Indication
Alcohol Use Disorder
Status
RECRUITING
Start date
2025-10-16
Primary completion
2028-04
Registered countries
Belgium, China, Germany, Japan, South Korea, Taiwan, United Kingdom, United States
Sites
115

The sponsor's registered location list, which states intent rather than approval.

clinicaltrials.govctgov registryverified 2026-11-07

Notes on the record

Supersedes the row verified 2026-09-28 (kept), per DATA LAYER rule 4. Read live from the ClinicalTrials.gov v2 API 2026-11-07 (https://clinicaltrials.gov/api/v2/studies/NCT07219953); record last update posted 2026-11-04. site_count 116 to 115 location entries; status, dates and the eight countries unchanged. Flagged by the collector (inbox/2026-11-05.json); collector proposal replaced by this live read.

Company

Through brenipatide (LY3537031): Lilly

Cited in

Issues quoting NCT07219953 in their own text.

Record history